Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Rizzieri

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
Transplantation and Cellular Therapy|September 21, 2025
Exploring Perspectives on Feasibility, Challenges, and Support Needs for Chlorhexidine Gluconate (CHG) Bathing in the Outpatient Setting for Hematopoietic Cell Transplant Recipients: A Qualitative StudyMarie-Michèle Sainvil, Ashley L Artese, Laura J Fish, et al.
The Journal of Clinical Investigation|June 10, 2014
Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftmentMitchell E Horwitz, Nelson J Chao, David A Rizzieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 22, 2013
Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant researchMehdi Hamadani, Wael Saber, Kwang Woo Ahn, et al.
In Vivo (Athens, Greece)|June 23, 2022
Co-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AMLDaniel H Albert, Neal C Goodwin, Angela M Davies, et al.
JAMA Oncology|June 5, 2020
Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic TransplantNilanjan Ghosh, Sairah Ahmed, Kwang Woo Ahn, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 10, 2021
A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit-positive Acute Myeloid LeukemiaAnjali S Advani, William Tse, Hong Li, et al.
Cancer|January 25, 2017
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysisFotios V Michelis, Vikas Gupta, Mei-Jie Zhang, et al.
American Journal of Hematology|March 13, 2020
Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effectsAnthony D Sung, Shekeab Jauhari, Sharareh Siamakpour-Reihani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 25, 2011
Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remissionSherif S Farag, Kati Maharry, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 6, 2013
Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphomaMehdi Hamadani, Wael Saber, Kwang Woo Ahn, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
Transplantation and Cellular Therapy|September 21, 2025
Exploring Perspectives on Feasibility, Challenges, and Support Needs for Chlorhexidine Gluconate (CHG) Bathing in the Outpatient Setting for Hematopoietic Cell Transplant Recipients: A Qualitative StudyMarie-Michèle Sainvil, Ashley L Artese, Laura J Fish, et al.
The Journal of Clinical Investigation|June 10, 2014
Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftmentMitchell E Horwitz, Nelson J Chao, David A Rizzieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 22, 2013
Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant researchMehdi Hamadani, Wael Saber, Kwang Woo Ahn, et al.
In Vivo (Athens, Greece)|June 23, 2022
Co-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AMLDaniel H Albert, Neal C Goodwin, Angela M Davies, et al.
JAMA Oncology|June 5, 2020
Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic TransplantNilanjan Ghosh, Sairah Ahmed, Kwang Woo Ahn, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 10, 2021
A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit-positive Acute Myeloid LeukemiaAnjali S Advani, William Tse, Hong Li, et al.
Cancer|January 25, 2017
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysisFotios V Michelis, Vikas Gupta, Mei-Jie Zhang, et al.
American Journal of Hematology|March 13, 2020
Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effectsAnthony D Sung, Shekeab Jauhari, Sharareh Siamakpour-Reihani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 25, 2011
Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remissionSherif S Farag, Kati Maharry, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 6, 2013
Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphomaMehdi Hamadani, Wael Saber, Kwang Woo Ahn, et al.
Pageof 14